ZA964683B - Epstein-barr virus peptides and antibodies against these peptides - Google Patents

Epstein-barr virus peptides and antibodies against these peptides

Info

Publication number
ZA964683B
ZA964683B ZA964683A ZA964683A ZA964683B ZA 964683 B ZA964683 B ZA 964683B ZA 964683 A ZA964683 A ZA 964683A ZA 964683 A ZA964683 A ZA 964683A ZA 964683 B ZA964683 B ZA 964683B
Authority
ZA
South Africa
Prior art keywords
peptides
ebv
epstein
barr virus
antibodies
Prior art date
Application number
ZA964683A
Other languages
English (en)
Inventor
Jaap Michael Middeldorp
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ZA964683B publication Critical patent/ZA964683B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16211Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2474/00Immunochemical assays or immunoassays characterised by detection mode or means of detection
    • G01N2474/20Immunohistochemistry assay
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/811Peptides or proteins is immobilized on, or in, an inorganic carrier

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ZA964683A 1995-06-06 1996-06-05 Epstein-barr virus peptides and antibodies against these peptides ZA964683B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95201486 1995-06-06

Publications (1)

Publication Number Publication Date
ZA964683B true ZA964683B (en) 1997-01-07

Family

ID=8220358

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA964683A ZA964683B (en) 1995-06-06 1996-06-05 Epstein-barr virus peptides and antibodies against these peptides

Country Status (13)

Country Link
US (2) US5843405A (de)
EP (1) EP0747481B1 (de)
JP (2) JP4319703B2 (de)
KR (1) KR100523972B1 (de)
AT (1) ATE211172T1 (de)
AU (1) AU707301B2 (de)
CA (1) CA2178057C (de)
DE (1) DE69618080T2 (de)
DK (1) DK0747481T3 (de)
ES (1) ES2170195T3 (de)
HK (1) HK1001164A1 (de)
PT (1) PT747481E (de)
ZA (1) ZA964683B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2824912B1 (fr) * 2001-05-18 2004-10-29 Jacques Gregoire Dispositif de kit elisa, base sur un antigene : proteines m dbp, du virus ebv, particulierement destine au diagnostic serologique du cancer npc, et le procede de preparation de cette proteine
JP2005060314A (ja) * 2003-08-13 2005-03-10 Masao Tanihara 化粧料
EP1827278B1 (de) 2004-11-15 2012-06-06 Biosense Webster, Inc. Katheter mit mikrofabrizierter temperaturmessung
EP2101177A1 (de) * 2008-03-10 2009-09-16 Universite Joseph Fourier Verwendung eines synthetischen Peptids aus dem ZEBRA-Protein für die in-vitro-Diagnose von Epstein-Barr-Virus (EBV)-Reaktivierung
GB201121308D0 (en) 2011-12-12 2012-01-25 Cell Medica Ltd Process
WO2013088114A1 (en) 2011-12-12 2013-06-20 Cell Medica Limited Process of expanding t cells
PL2812431T3 (pl) 2012-02-09 2020-02-28 Baylor College Of Medicine Mieszanki peptydowe do wytwarzania wielowirusowych CTL o szerokiej swoistości
CN113791213A (zh) 2015-09-18 2021-12-14 贝勒医学院 来自病原体的免疫原性抗原鉴定以及与临床效力的相关性
US10772914B1 (en) * 2019-04-18 2020-09-15 Baylor College Of Medicine EBV-specific immune cells
CN111690056B (zh) * 2020-04-30 2021-12-21 清华大学 一种中和eb病毒的单克隆抗体及其应用
CN111574621B (zh) * 2020-04-30 2022-03-29 中山大学肿瘤防治中心(中山大学附属肿瘤医院、中山大学肿瘤研究所) 一种中和eb病毒的单克隆抗体及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61257188A (ja) * 1984-08-23 1986-11-14 ハンス ヨツト ヴオルフ Ebvゲノムのdna配列、組換えdna分子、ならびにebv関連抗原および該抗原を含有する診断用組成物および製剤組成物の製造法
DE3583564D1 (de) * 1984-08-23 1991-08-29 Hans Joachim Wolf Dna-sequenzen des ebv-genoms, rekombinante dna-molekuele, verfahren zur herstellung von ebv-verwandten antigenen sowie diagnostische zusammensetzungen und pharmazeutische zusammensetzungen, die die genannten antigene enthalten.
US5256768A (en) * 1985-12-13 1993-10-26 The Johns Hopkins University Expression of antigenic Epstein-Barr virus polypeptides in bacteria and their use in diagnostics
US4761470A (en) * 1985-12-16 1988-08-02 Merck & Co., Inc. Immunogenic synthetic peptide capable of eliciting herpes simplex virus neutralizing antibody
US5087557A (en) * 1986-06-23 1992-02-11 Genetic Systems Corporation Human monoclonal antibody to lymphadenopathy-associated virus
US4879213A (en) * 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse

Also Published As

Publication number Publication date
AU5479396A (en) 1996-12-19
CA2178057A1 (en) 1996-12-07
JP2008188017A (ja) 2008-08-21
HK1001164A1 (en) 1998-05-29
EP0747481A1 (de) 1996-12-11
ES2170195T3 (es) 2002-08-01
DK0747481T3 (da) 2002-04-08
DE69618080D1 (de) 2002-01-31
KR100523972B1 (ko) 2006-04-14
PT747481E (pt) 2002-05-31
AU707301B2 (en) 1999-07-08
JPH0925295A (ja) 1997-01-28
JP4612071B2 (ja) 2011-01-12
DE69618080T2 (de) 2002-06-13
US6143865A (en) 2000-11-07
CA2178057C (en) 2010-08-03
US5843405A (en) 1998-12-01
ATE211172T1 (de) 2002-01-15
JP4319703B2 (ja) 2009-08-26
EP0747481B1 (de) 2001-12-19

Similar Documents

Publication Publication Date Title
Zhao et al. Protein epitope mapping by mass spectrometry
BR9809443A (pt) Polipeptìdeo compreendendo uma porção antigênica de um antìgeno de m. tuberculosis, molécula de dna, vetor recombinante de expressão, célula hospedeira, processo para detecção de infecção de m. tuberculosis em uma amostra biológica, kit de diganóstico, anticorpo monoclonal, anticorpo policlonal, e, proteìna de fusão.
EP1104887A3 (de) Verfahren und Testsatz zur Bestimmung von Kollagenfragmenten in Körperflüssigkeiten
ZA964683B (en) Epstein-barr virus peptides and antibodies against these peptides
HUP0103650A2 (hu) Vírusburok-proteinek epitópjai és az ellenük termelt ellenanyagok alkalmazása HCV-vírusantigén gazdaszövetből történő kimutatására
EP2048505A3 (de) Verfahren zur Früherkennung der Serokonversion eines gegen Hepatitis C-Virus gerichteten Antikörpers
ZA976196B (en) Peptide reagent for the detection of human cytomegalovirus (cmv)
GR3018371T3 (en) Method for identifying or determining proteins and applications therefor.
KR950008537A (ko) 엡스타인 바 비루스(ebv)에 대한 항체의 검출용 진단제
CA2120342A1 (en) Epstein-barr virus peptides and antibodies against these peptides
Wieslander et al. Anti-basement membrane antibody: immunoenzymatic assay and specificity of antibodies
FI103975B1 (fi) Immunodiagnostinen nivelreumakoe
KR940005666A (ko) C형 간염 바이러스를 분류하기 위한 항원성 펩티드 ,이 펩티드를 포함하는 키트 및 이 펩티드를 사용하여 c형 간염 바이러스를 분류하는 방법
DE69534263D1 (de) Expression kassette eines proteines p30 aus toxoplasma gondii
CA2259967A1 (en) Peptide reagent for the detection of human cytomegalovirus (cmv)
EP0985931A3 (de) Rekombinantes-Antigen-Immunoassay zur Diagnose von Syphilis
ATE228249T1 (de) Immuntest zum nachweis von menschlichen cytomegalovirus spezifischen igm
IT1250367B (it) Materiale proteico legante anticorpi contro il citomegalovirus umano e reagenti diagnostici derivati da tale materiale proteico.
AU6642698A (en) Immunoassay and kit for iga antibodies specific for acetaldehyde adducts
RU2000124671A (ru) Эпитопы в белках вирусной оболочки и специфические антитела, направленные против этих эпитопов: применение для обнаружения антигена вируса hcv в ткани хозяина
IT1250366B (it) Materiale proteico ricombinante legante anticorpi contro il cigalomegavirus umano, reagenti diagnostici derivati da tale materialeproteico e plasmide ricombinante esprimente lo stesso.